Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Eugene Braunwald

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Devices

Electrocardiography

Phenomena

Recurrence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
118
Cannon, Christopher
115
Antman, Elliott
114
Murphy, Sabina
95
McCabe, Carolyn
81
Gibson, Michael
80
Morrow, David
56
Giugliano, Robert
54
Sabatine, Marc
44
Pfeffer, Marc
41
Wiviott, Stephen
33
de Lemos, James
28
Califf, Robert
25
Van de Werf, Frans
23
Rifai, Nader
21
Rouleau, Jean-Lucien

Sign-in to see all Coauthors

Publications

TOP 3
Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndrome.
Braunwald Eugene
Biomarkers in heart failure. Preface.
O'Donoghue Michelle L; Braunwald Eugene; Antman Elliott M; Murphy Sabina A; Bates Eric R; Rozenman Yoseph; Michelson Alan D; Hautvast Raymond W; Ver Lee Peter N; Close Sandra L; Shen Lei; Mega Jessica L; Sabatine Marc S; Wiviott Stephen D
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Eugene Braunwald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2009;54(16):1544-55.
2009: Braunwald Eugene
Biomarkers in heart failure. Preface.
Heart failure clinics 2009;5(4):xiii-xiv.
2009: O'Donoghue Michelle L; Braunwald Eugene; Antman Elliott M; Murphy Sabina A; Bates Eric R; Rozenman Yoseph; Michelson Alan D; Hautvast Raymond W; Ver Lee Peter N; Close Sandra L; Shen Lei; Mega Jessica L; Sabatine Marc S; Wiviott Stephen D
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
Lancet 2009;374(9694):989-97.
2009: Sabatine Marc S; Antman Elliott M; Widimsky Petr; Ebrahim Iftikhar O; Kiss Robert G; Saaiman André; Polasek Rostislav; Contant Charles F; McCabe Carolyn H; Braunwald Eugene
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.
Lancet 2009;374(9692):787-95.
2009: Wilson Sean R; Sabatine Marc S; Braunwald Eugene; Sloan Sarah; Murphy Sabina A; Morrow David A
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
American heart journal 2009;158(3):386-91.
2009: Morrow David A; Scirica Benjamin M; Fox Keith A A; Berman Gail; Strony John; Veltri Enrico; Bonaca Marc P; Fish Polly; McCabe Carolyn H; Braunwald Eugene;
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
American heart journal 2009;158(3):335-341.e3.
2009: Pride Yuri B; Wiviott Stephen D; Buros Jacqueline L; Zorkun Cafer; Tariq M Umer; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
American heart journal 2009;158(3):e21-6.
2009: O'Donoghue Michelle; Antman Elliott M; Braunwald Eugene; Murphy Sabina A; Steg P Gabriel; Finkelstein Ariel; Penny William F; Fridrich Viliam; McCabe Carolyn H; Sabatine Marc S; Wiviott Stephen D
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
Journal of the American College of Cardiology 2009;54(8):678-85.
2009: Braunwald Eugene
Acute coronary syndromes: BNP measurement predicts AMI risk in the elderly.
Nature reviews. Cardiology 2009;6(8):503-4.
2009: Wrishko Rebecca E; Ernest C Steven; Small David S; Li Ying G; Weerakkody Govinda J; Riesmeyer Jeffrey R; Macias William L; Rohatagi Shashank; Salazar Daniel E; Antman Elliott M; Wiviott Stephen D; Braunwald Eugene; Ni Lan
Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.
Journal of clinical pharmacology 2009;49(8):984-98.
2009: Braunwald Eugene
Adventures in cardiovascular research.
Circulation 2009;120(2):170-80.
2009: Maron Barry J; Maron Martin S; Wigle E Douglas; Braunwald Eugene
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2009;54(3):191-200.
2009: Michelson Alan D; Frelinger Andrew L; Braunwald Eugene; Downey William E; Angiolillo Dominick J; Xenopoulos Nicholas P; Jakubowski Joseph A; Li Youfu; Murphy Sabina A; Qin Jie; McCabe Carolyn H; Antman Elliott M; Wiviott Stephen D;
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
European heart journal 2009;30(14):1753-63.
2009: Braunwald Eugene
Noninvasive detection of vulnerable coronary plaques: Locking the barn door before the horse is stolen.
Journal of the American College of Cardiology 2009;54(1):58-9.
2009: Morrow David A; Wiviott Stephen D; White Harvey D; Nicolau Jose C; Bramucci Ezio; Murphy Sabina A; Bonaca Marc P; Ruff Christian T; Scirica Benjamin M; McCabe Carolyn H; Antman Elliott M; Braunwald Eugene
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation 2009;119(21):2758-64.
2009: Charytan David M; Wallentin Lars; Lagerqvist Bo; Spacek Rudolf; De Winter Robbert J; Stern Noam M; Braunwald Eugene; Cannon Christopher P; Choudhry Niteesh K
Early angiography in patients with chronic kidney disease: a collaborative systematic review.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(6):1032-43.
2009: Lewis Eldrin F; Solomon Scott D; Jablonski Kathleen A; Rice Madeline Murguia; Clemenza Francesco; Hsia Judith; Maggioni Aldo P; Zabalgoitia Miguel; Huynh Thao; Cuddy Thomas E; Gersh Bernard J; Rouleau Jean; Braunwald Eugene; Pfeffer Marc A;
Predictors of heart failure in patients with stable coronary artery disease: a PEACE study.
Circulation. Heart failure 2009;2(3):209-16.
2009: Mega Jessica L; Close Sandra L; Wiviott Stephen D; Shen Lei; Hockett Richard D; Brandt John T; Walker Joseph R; Antman Elliott M; Macias William L; Braunwald Eugene; Sabatine Marc S
Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
Circulation 2009;119(19):2553-60.
2009: Giugliano Robert P; White Jennifer A; Bode Christoph; Armstrong Paul W; Montalescot Gilles; Lewis Basil S; van 't Hof Arnoud; Berdan Lisa G; Lee Kerry L; Strony John T; Hildemann Steven; Veltri Enrico; Van de Werf Frans; Braunwald Eugene; Harrington Robert A; Califf Robert M; Newby L Kristin;
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2176-90.
2009: Wilson Sean R; Scirica Benjamin M; Braunwald Eugene; Murphy Sabina A; Karwatowska-Prokopczuk Ewa; Buros Jacqueline L; Chaitman Bernard R; Morrow David A
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Journal of the American College of Cardiology 2009;53(17):1510-6.
2009: Scirica Benjamin M; Morrow David A; Budaj Andrzej; Dalby Anthony J; Mohanavelu Satishkumar; Qin Jie; Aroesty Julian; Hedgepeth Chester M; Stone Peter H; Braunwald Eugene
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
Journal of the American College of Cardiology 2009;53(16):1411-21.
2009: Morrow David A; Scirica Benjamin M; Chaitman Bernard R; McGuire Darren K; Murphy Sabina A; Karwatowska-Prokopczuk Ewa; McCabe Carolyn H; Braunwald Eugene;
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Circulation 2009;119(15):2032-9.
2009: Truong Quynh A; Cannon Christopher P; Zakai Neil A; Rogers Ian S; Giugliano Robert P; Wiviott Stephen D; McCabe Carolyn H; Morrow David A; Braunwald Eugene
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
American heart journal 2009;157(4):673-9.e1.
2009: Giraldez Roberto R; Sabatine Marc S; Morrow David A; Mohanavelu Satishkumar; McCabe Carolyn H; Antman Elliott M; Braunwald Eugene
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction.
American heart journal 2009;157(3):517-24.
2009: Ray Kausik K; Cannon Christopher P; Cairns Richard; Morrow David A; Ridker Paul M; Braunwald Eugene
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(3):424-30.
2009: Montalescot Gilles; Wiviott Stephen D; Braunwald Eugene; Murphy Sabina A; Gibson C Michael; McCabe Carolyn H; Antman Elliott M;
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
Lancet 2009;373(9665):723-31.
2009: Scirica Benjamin M; Cannon Christopher P; Sabatine Marc S; Jarolim Petr; Sloane Sarah; Rifai Nader; Braunwald Eugene; Morrow David A;
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
Clinical chemistry 2009;55(2):265-73.
2009: Felker G Michael; O'Connor Christopher M; Braunwald Eugene;
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?
Circulation. Heart failure 2009;2(1):56-62.
2009: Mega Jessica L; Close Sandra L; Wiviott Stephen D; Shen Lei; Hockett Richard D; Brandt John T; Walker Joseph R; Antman Elliott M; Macias William; Braunwald Eugene; Sabatine Marc S
Cytochrome p-450 polymorphisms and response to clopidogrel.
The New England journal of medicine 2009;360(4):354-62.
2009: Sabatine Marc S; Morrow David A; de Lemos James A; Jarolim Petr; Braunwald Eugene
Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.
European heart journal 2009;30(2):162-9.
2008: Ahmed Shaheeda; Cannon Christopher P; Giugliano Robert P; Murphy Sabina A; Morrow David A; Antman Elliott M; Braunwald Eugene; Gibson C Michael
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.
International journal of cardiology 2008;131(1):105-12.
2008: Cannon Christopher P; Giugliano Robert P; Blazing Michael A; Harrington Robert A; Peterson John L; Sisk Christine McCrary; Strony John; Musliner Thomas A; McCabe Carolyn H; Veltri Enrico; Braunwald Eugene; Califf Robert M;
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
American heart journal 2008;156(5):826-32.
2008: Maron Barry J; Bonow Robert O; Salberg Lisa; Roberts William C; Braunwald Eugene
The first patient clinically diagnosed with hypertrophic cardiomyopathy.
The American journal of cardiology 2008;102(10):1418-20.
2008: Domanski Michael; Tian Xin; Fleg Jerome; Coady Sean; Gosen Christine; Kirby Ruth; Sachdev Vandana; Knatterud Genell; Braunwald Eugene
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
The American journal of cardiology 2008;102(8):1023-7.
2008: Marbán Eduardo; Braunwald Eugene
Training the clinician investigator.
Circulation research 2008;103(8):771-2.
2008: Wiviott Stephen D; Braunwald Eugene; Angiolillo Dominick J; Meisel Simha; Dalby Anthony J; Verheugt Freek W A; Goodman Shaun G; Corbalan Ramon; Purdy Drew A; Murphy Sabina A; McCabe Carolyn H; Antman Elliott M;
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Circulation 2008;118(16):1626-36.
2008: Murphy Sabina A; Antman Elliott M; Wiviott Stephen D; Weerakkody Govinda; Morocutti Giorgio; Huber Kurt; Lopez-Sendon Jose; McCabe Carolyn H; Braunwald Eugene;
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial.
European heart journal 2008;29(20):2473-9.
2008: Olenchock Benjamin A; Wiviott Stephen D; Murphy Sabina A; Cannon Christopher P; Rifai Nader; Braunwald Eugene; Morrow David A
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16.
Journal of thrombosis and thrombolysis 2008;26(2):79-84.
2008: Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2008;52(13):1095-103.
2008: Giraldez Roberto R; Giugliano Robert P; Mohanavelu Satishkumar; Murphy Sabina A; McCabe Carolyn H; Cannon Christopher P; Braunwald Eugene
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Journal of the American College of Cardiology 2008;52(11):914-20.
2008: Maisel Alan; Mueller Christian; Adams Kirkwood; Anker Stefan D; Aspromonte Nadia; Cleland John G F; Cohen-Solal Alain; Dahlstrom Ulf; DeMaria Anthony; Di Somma Salvatore; Filippatos Gerasimos S; Fonarow Gregg C; Jourdain Patrick; Komajda Michel; Liu Peter P; McDonagh Theresa; McDonald Kenneth; Mebazaa Alexandre; Nieminen Markku S; Peacock W Frank; Tubaro Marco; Valle Roberto; Vanderhyden Marc; Yancy Clyde W; Zannad Faiez; Braunwald Eugene
State of the art: using natriuretic peptide levels in clinical practice.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(9):824-39.
2008: Brilakis Emmanouil S; de Lemos James A; Cannon Christopher P; Wiviott Stephen D; Murphy Sabina A; Morrow David A; Sabatine Marc S; Banerjee Subhash; Blazing Michael A; Califf Robert M; Braunwald Eugene
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
The American journal of cardiology 2008;102(5):552-8.
2008: O'Donoghue Michelle; Boden William E; Braunwald Eugene; Cannon Christopher P; Clayton Tim C; de Winter Robbert J; Fox Keith A A; Lagerqvist Bo; McCullough Peter A; Murphy Sabina A; Spacek Rudolf; Swahn Eva; Wallentin Lars; Windhausen Fons; Sabatine Marc S
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis.
JAMA : the journal of the American Medical Association 2008;300(1):71-80.
2008: Braunwald Eugene
The management of heart failure: the past, the present, and the future.
Circulation. Heart failure 2008;1(1):58-62.
2008: Antman Elliott M; Wiviott Stephen D; Murphy Sabina A; Voitk Juri; Hasin Yonathan; Widimsky Petr; Chandna Harish; Macias William; McCabe Carolyn H; Braunwald Eugene
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Journal of the American College of Cardiology 2008;51(21):2028-33.
2008: Braunwald Eugene
Biomarkers in heart failure.
The New England journal of medicine 2008;358(20):2148-59.
2008: Wiviott Stephen D; Braunwald Eugene; Murphy Sabina A; Antman Elliott M;
A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.
The American journal of cardiology 2008;101(9):1367-70.
2008: Gibson C Michael; Pride Yuri B; Buros Jacqueline L; Kunadian Vijayalakshmi; Southard Matthew C; Harrigan Caitlin J; Ciaglo Lauren N; Sabatine Marc S; Cannon Christopher P; Braunwald Eugene
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
The American journal of cardiology 2008;101(9):1232-8.
2008: Pollack Charles V; Braunwald Eugene
2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice.
Annals of emergency medicine 2008;51(5):591-606.
2008: Braunwald Eugene
The American Society for Clinical Investigation, 1952--1975: a personal perspective.
The Journal of clinical investigation 2008;118(4):1228-30.
2008: Wiviott Stephen D; Braunwald Eugene; McCabe Carolyn H; Horvath Ivan; Keltai Matyas; Herrman Jean-Paul R; Van de Werf Frans; Downey William E; Scirica Benjamin M; Murphy Sabina A; Antman Elliott M;
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Lancet 2008;371(9621):1353-63.
2008: Mielniczuk Lisa M; Pfeffer Marc A; Lewis Eldrin F; Blazing Michael A; de Lemos James A; Shui Amy; Mohanavelu Satish; Califf Robert M; Braunwald Eugene
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
American heart journal 2008;155(4):725-31.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Antiplatelet therapy and platelet function testing.
Clinical cardiology 2008;31(3 Suppl 1):I36.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Clinical cardiology 2008;31(3 Suppl 1):I28-35.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Investigating the mechanisms of hyporesponse to antiplatelet approaches.
Clinical cardiology 2008;31(3 Suppl 1):I21-7.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
Clinical cardiology 2008;31(3 Suppl 1):I2-9.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention.
Clinical cardiology 2008;31(3 Suppl 1):I17-20.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Assessing the current role of platelet function testing.
Clinical cardiology 2008;31(3 Suppl 1):I10-6.
2008: Braunwald Eugene; Angiolillo Dominick; Bates Eric; Berger Peter B; Bhatt Deepak; Cannon Christopher P; Furman Mark I; Gurbel Paul; Michelson Alan D; Peterson Eric; Wiviott Stephen
Antiplatelet therapy and platelet function testing. Introduction.
Clinical cardiology 2008;31(3 Suppl 1):I1.
2008: Sabatine Marc S; Ploughman Lynn; Simonsen Katy L; Iakoubova Olga A; Kirchgessner Todd G; Ranade Koustubh; Tsuchihashi Zenta; Zerba Kim E; Long Diane U; Tong Carmen H; Packard Christopher J; Pfeffer Marc A; Devlin James J; Shepherd James; Campos Hannia; Sacks Frank M; Braunwald Eugene
Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):562-7.
2008: Braunwald Eugene
JACC: Cardiovascular Interventions: the end of the beginning.
JACC. Cardiovascular interventions 2008;1(1):1-2.
2008: Miller Michael; Cannon Christopher P; Murphy Sabina A; Qin Jie; Ray Kausik K; Braunwald Eugene;
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.
Journal of the American College of Cardiology 2008;51(7):724-30.
2008: Iakoubova Olga A; Sabatine Marc S; Rowland Charles M; Tong Carmen H; Catanese Joseph J; Ranade Koustubh; Simonsen Katy L; Kirchgessner Todd G; Cannon Christopher P; Devlin James J; Braunwald Eugene
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
Journal of the American College of Cardiology 2008;51(4):449-55.
2008: Iakoubova Olga A; Tong Carmen H; Rowland Charles M; Kirchgessner Todd G; Young Bradford A; Arellano Andre R; Shiffman Dov; Sabatine Marc S; Campos Hannia; Packard Christopher J; Pfeffer Marc A; White Thomas J; Braunwald Eugene; Shepherd James; Devlin James J; Sacks Frank M
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
Journal of the American College of Cardiology 2008;51(4):435-43.
2008: Gibson C Michael; Murphy Sabina A; Pride Yuri B; Kirtane Ajay J; Aroesty Julian M; Stein Erica B; Ciaglo Lauren N; Southard Matthew C; Sabatine Marc S; Cannon Christopher P; Braunwald Eugene;
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
American heart journal 2008;155(1):133-9.
2008: Morrow David A; Wang Yunmei; Croce Kevin; Sakuma Masashi; Sabatine Marc S; Gao Huiyun; Pradhan Aruna D; Healy Aileen M; Buros Jacki; McCabe Carolyn H; Libby Peter; Cannon Christopher P; Braunwald Eugene; Simon Daniel I
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
American heart journal 2008;155(1):49-55.
2008: Ahmed Ali; Pitt Bertram; Rahimtoola Shahbudin H; Waagstein Finn; White Michel; Love Thomas E; Braunwald Eugene
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
International journal of cardiology 2008;123(2):138-46.
2007: Wijns William; Braunwald Eugene;
Advancing the knowledge base on the efficacy-safety ratio with drug-eluting stents contributions from the European Society of Cardiology Congress, Vienna, Austria, September 1-5, 2007.
Journal of the American College of Cardiology 2007;50(25):2431-3.
2007: Wiviott Stephen D; Trenk Dietmar; Frelinger Andrew L; O'Donoghue Michelle; Neumann Franz-Josef; Michelson Alan D; Angiolillo Dominick J; Hod Hanoch; Montalescot Gilles; Miller Debra L; Jakubowski Joseph A; Cairns Richard; Murphy Sabina A; McCabe Carolyn H; Antman Elliott M; Braunwald Eugene;
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Circulation 2007;116(25):2923-32.
2007: Morrow David A; Antman Elliott M; Murphy Sabina A; Qin Jie; Ruda Mikhail; Guneri Sema; Jacob Ashok Joseph; Budaj Andrzej; Braunwald Eugene;
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
American heart journal 2007;154(6):1078-84, 1084.e1.
2007: Solomon Scott D; Lin Julie; Solomon Caren G; Jablonski Kathleen A; Rice Madeline Murguia; Steffes Michael; Domanski Michael; Hsia Judith; Gersh Bernard J; Arnold J Malcolm O; Rouleau Jean; Braunwald Eugene; Pfeffer Marc A;
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.
Circulation 2007;116(23):2687-93.
2007: de Lemos James A; Morrow David A; Blazing Michael A; Jarolim Petr; Wiviott Stephen D; Sabatine Marc S; Califf Robert M; Braunwald Eugene
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
Journal of the American College of Cardiology 2007;50(22):2117-24.
2007: Wiviott Stephen D; Braunwald Eugene; McCabe Carolyn H; Montalescot Gilles; Ruzyllo Witold; Gottlieb Shmuel; Neumann Franz-Joseph; Ardissino Diego; De Servi Stefano; Murphy Sabina A; Riesmeyer Jeffrey; Weerakkody Govinda; Gibson C Michael; Antman Elliott M;
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine 2007;357(20):2001-15.
2007: Ruff Christian T; Wiviott Stephen D; Morrow David A; Mohanavelu Satishkumar; Murphy Sabina A; Antman Elliott M; Braunwald Eugene;
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.
The American journal of medicine 2007;120(11):993-8.
2007: Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2007;50(14):1386-95.
2007: Murphy Sabina A; Cannon Christopher P; Wiviott Stephen D; de Lemos James A; Blazing Michael A; McCabe Carolyn H; Califf Robert M; Braunwald Eugene
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
The American journal of cardiology 2007;100(7):1047-51.
2007: Scirica Benjamin M; Morrow David A; Hod Hanoch; Murphy Sabina A; Belardinelli Luiz; Hedgepeth Chester M; Molhoek Peter; Verheugt Freek W A; Gersh Bernard J; McCabe Carolyn H; Braunwald Eugene
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Circulation 2007;116(15):1647-52.
2007: Scirica Benjamin M; Morrow David A; Cannon Christopher P; de Lemos James A; Murphy Sabina; Sabatine Marc S; Wiviott Stephen D; Rifai Nader; McCabe Carolyn H; Braunwald Eugene;
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes.
Clinical chemistry 2007;53(10):1800-7.
2007: Scirica Benjamin M; Morrow David A; Sadowski Zygmunt; Ruda Mikhail; Nicolau José Carlos; Giugliano Robert P; Wiviott Stephen D; Sabatine Marc S; Shui Amy; Antman Elliott M; Braunwald Eugene
A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study.
European heart journal 2007;28(17):2070-6.
2007: Murphy Sabina A; Gibson Charles Michael; Morrow David A; Van de Werf Frans; Menown Ian B; Goodman Shaun G; Mahaffey Kenneth W; Cohen Marc; McCabe Carolyn H; Antman Elliott M; Braunwald Eugene
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis.
European heart journal 2007;28(17):2077-86.
2007: Omland Torbjørn; Sabatine Marc S; Jablonski Kathleen A; Rice Madeline Murguia; Hsia Judith; Wergeland Ragnhild; Landaas Sverre; Rouleau Jean L; Domanski Michael J; Hall Christian; Pfeffer Marc A; Braunwald Eugene;
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Journal of the American College of Cardiology 2007;50(3):205-14.
2007: Braunwald Eugene
Reducing myocardial injury by minimizing imbalance between oxygen supply and demand.
Anesthesiology 2007;107(1):161-3.
2007: Giugliano Robert P; Wiviott Stephen D; Stone Peter H; Simon Daniel I; Schweiger Marc J; Bouchard Alain; Leesar Massoud A; Goulder Michael A; Deitcher Steven R; McCabe Carolyn H; Braunwald Eugene;
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial.
Journal of the American College of Cardiology 2007;49(25):2398-407.
2007: Sabatine Marc S; Morrow David A; Dalby Anthony; Pfisterer Mathias; Duris Tibor; Lopez-Sendon Jose; Murphy Sabina A; Gao Runlin; Antman Elliott M; Braunwald Eugene;
Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Journal of the American College of Cardiology 2007;49(23):2256-63.
2007: Fox Keith A A; Antman Elliott M; Montalescot Gilles; Agewall Stefan; SomaRaju Bhupathi; Verheugt Freek W A; Lopez-Sendon Jose; Hod Hanoch; Murphy Sabina A; Braunwald Eugene
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.
Journal of the American College of Cardiology 2007;49(23):2249-55.
2007: Gibson C Michael; Murphy Sabina A; Montalescot Gilles; Morrow David A; Ardissino Diego; Cohen Marc; Gulba Dietrich C; Kracoff Oscar H; Lewis Basil S; Roguin Nathan; Antman Elliott M; Braunwald Eugene;
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Journal of the American College of Cardiology 2007;49(23):2238-46.
2007: Ray Kausik K; Morrow David A; Sabatine Marc S; Shui Amy; Rifai Nader; Cannon Christopher P; Braunwald Eugene
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
Circulation 2007;115(24):3071-8.
2007: Mega Jessica L; Morrow David A; Ostör Erika; Dorobantu Maria; Qin Jie; Antman Elliott M; Braunwald Eugene
Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction.
Circulation 2007;115(22):2822-8.
2007: White Harvey D; Braunwald Eugene; Murphy Sabina A; Jacob Ashok J; Gotcheva Nina; Polonetsky Leonid; Antman Elliott M
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.
European heart journal 2007;28(9):1066-71.
2007: Morrow David A; Scirica Benjamin M; Karwatowska-Prokopczuk Ewa; Murphy Sabina A; Budaj Andrzej; Varshavsky Sergei; Wolff Andrew A; Skene Allan; McCabe Carolyn H; Braunwald Eugene;
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
JAMA : the journal of the American Medical Association 2007;297(16):1775-83.
2007: Ray Kausik K; Cannon Christopher P; Morrow David A; Kirtane Ajay J; Buros Jacqueline; Rifai Nader; McCabe Carolyn H; Gibson C Michael; Braunwald Eugene
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
European heart journal 2007;28(7):806-13.
2007: Sabatine Marc S; Morrow David A; Jablonski Kathleen A; Rice Madeline Murguia; Warnica J Wayne; Domanski Michael J; Hsia Judith; Gersh Bernard J; Rifai Nader; Ridker Paul M; Pfeffer Marc A; Braunwald Eugene;
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Circulation 2007;115(12):1528-36.
2007: Wittes Janet; Barrett-Connor Elizabeth; Braunwald Eugene; Chesney Margaret; Cohen Harvey Jay; Demets David; Dunn Leo; Dwyer Johanna; Heaney Robert P; Vogel Victor; Walters Leroy; Yusuf Salim
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
Clinical trials (London, England) 2007;4(3):218-34.
2006: Scirica Benjamin M; Cannon Christopher P; Cooper Richard; Aster Richard H; Brassard Jacqueline; McCabe Carolyn H; Charlesworth Andrew; Skene Allan M; Braunwald Eugene
Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial.
Journal of thrombosis and thrombolysis 2006;22(2):95-102.
2006: Gibson C Michael; Kirtane Ajay J; Morrow David A; Palabrica Theresa M; Murphy Sabina A; Stone Peter H; Scirica Benjamin M; Jennings Lisa K; Herrmann Howard C; Cohen David J; McCabe Carolyn H; Braunwald Eugene;
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
American heart journal 2006;152(4):756-61.
2006: Gibson C Michael; Kirtane Ajay J; Murphy Sabina A; Rohrbeck Steve; Menon Venu; Lins Jeffrey; Kazziha Samer; Rokos Ivan; Shammas Nicolas W; Palabrica Theresa M; Fish Polly; McCabe Carolyn H; Braunwald Eugene;
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
American heart journal 2006;152(4):668-75.
2006: Wiviott Stephen D; Antman Elliott M; Gibson C Michael; Montalescot Gilles; Riesmeyer Jeffrey; Weerakkody Govinda; Winters Kenneth J; Warmke Jeffrey W; McCabe Carolyn H; Braunwald Eugene;
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
American heart journal 2006;152(4):627-35.
2006: Ahmed Shaheeda; Cannon Christopher P; Murphy Sabina A; Braunwald Eugene
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial.
European heart journal 2006;27(19):2323-9.
2006: Ray Kausik K; Bach Richard G; Cannon Christopher P; Cairns Richard; Kirtane Ajay J; Wiviott Stephen D; McCabe Carolyn H; Braunwald Eugene; Gibson C Michael;
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.
European heart journal 2006;27(19):2310-6.
2006: de Lemos James A; Wiviott Stephen D; Murphy Sabina A; Blazing Michael A; Lewis Eldrin F; Califf Robert M; Pfeffer Marc A; Braunwald Eugene
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial.
The American journal of cardiology 2006;98(6):739-42.
2006: Cannon Christopher P; Steinberg Benjamin A; Murphy Sabina A; Mega Jessica L; Braunwald Eugene
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.
Journal of the American College of Cardiology 2006;48(3):438-45.
2006: Mega Jessica L; Morrow David A; Cannon Christopher P; Murphy Sabina; Cairns Richard; Ridker Paul M; Braunwald Eugene
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
Journal of thrombosis and thrombolysis 2006;22(1):71-6.
2006: Morrow David A; de Lemos James A; Sabatine Marc S; Wiviott Stephen D; Blazing Michael A; Shui Amy; Rifai Nader; Califf Robert M; Braunwald Eugene
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
Circulation 2006;114(4):281-8.
2006: Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(2):386-95.
2006: Scirica Benjamin M; Sabatine Marc S; Morrow David A; Gibson C Michael; Murphy Sabina A; Wiviott Stephen D; Giugliano Robert P; McCabe Carolyn H; Cannon Christopher P; Braunwald Eugene
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study.
Journal of the American College of Cardiology 2006;48(1):37-42.
2006: Solomon Scott D; Rice Madeline M; A Jablonski Kathleen; Jose Powell; Domanski Michael; Sabatine Marc; Gersh Bernard J; Rouleau Jean; Pfeffer Marc A; Braunwald Eugene;
Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
Circulation 2006;114(1):26-31.
2006: Ly Hung Q; Kirtane Ajay J; Murphy Sabina A; Buros Jacki; Cannon Christopher P; Braunwald Eugene; Gibson C Michael;
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).
The American journal of cardiology 2006;98(1):1-5.
2006: Gibson C Michael; Morrow David A; Murphy Sabina A; Palabrica Theresa M; Jennings Lisa K; Stone Peter H; Lui Henry H; Bulle Thomas; Lakkis Nasser; Kovach Richard; Cohen David J; Fish Polly; McCabe Carolyn H; Braunwald Eugene;
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
Journal of the American College of Cardiology 2006;47(12):2364-73.
2006: Roe Matthew T; Peterson Eric D; Newby L Kristin; Chen Anita Y; Pollack Charles V; Brindis Ralph G; Harrington Robert A; Christenson Robert H; Smith Sidney C; Califf Robert M; Braunwald Eugene; Gibler W Brian; Ohman E Magnus
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2006;151(6):1205-13.
2006: Morrow David A; Scirica Benjamin M; Karwatowska-Prokopczuk Ewa; Skene Allan; McCabe Carolyn H; Braunwald Eugene;
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
American heart journal 2006;151(6):1186.e1-9.
2006: Braunwald Eugene
Departments, divisions and centers in the evolution of medical schools.
The American journal of medicine 2006;119(6):457-62.
2006: Scirica Benjamin M; Morrow David A; Cannon Christopher P; Ray Kausik K; Sabatine Marc S; Jarolim Petr; Shui Amy; McCabe Carolyn H; Braunwald Eugene;
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.
Journal of the American College of Cardiology 2006;47(11):2326-31.
2006: Bhadriraju Satish; Ray Kausik K; DeFranco Anthony C; Barber Kim; Bhadriraju Padmini; Murphy Sabina A; Morrow David A; McCabe Carolyn H; Gibson C Michael; Cannon Christopher P; Braunwald Eugene
Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial.
The American journal of cardiology 2006;97(11):1573-7.
2006: Tonelli Marcello; Jose Powell; Curhan Gary; Sacks Frank; Braunwald Eugene; Pfeffer Marc;
Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial.
BMJ (Clinical research ed.) 2006;332(7555):1426.
2006: Domanski Michael J; Jablonski Kathleen A; Rice Madeline Murguia; Fowler Sarah E; Braunwald Eugene;
Obesity and cardiovascular events in patients with established coronary disease.
European heart journal 2006;27(12):1416-22.
2006: Dumaine Raphaelle; Gibson C Michael; Murphy Sabina A; Southard Matthew; Ly Hung Q; McCabe Carolyn H; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(5):315-22.
2006: Braunwald Eugene
Epilogue: what do clinicians expect from imagers?
Journal of the American College of Cardiology 2006;47(8 Suppl):C101-3.
2006: Jose Powell; Tomson Charles; Skali Hicham; Rouleau Jean; Braunwald Eugene; Arnold J Malcolm; Cuddy Thomas; Sussex Bruce; Bernstein Victoria; Pfeffer Marc; Solomon Scott
Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.
Journal of the American College of Cardiology 2006;47(8):1725-7.
2006: Wiviott Stephen D; Morrow David A; Frederick Paul D; Antman Elliott M; Braunwald Eugene;
Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
Journal of the American College of Cardiology 2006;47(8):1553-8.
2006: Ahmed Shaheeda; Antman Elliott M; Murphy Sabina A; Giugliano Robert P; Cannon Christopher P; White Harvey; Morrow David A; Braunwald Eugene
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).
Journal of thrombosis and thrombolysis 2006;21(2):119-29.
2006: Antman Elliott M; Morrow David A; McCabe Carolyn H; Murphy Sabina A; Ruda Mikhail; Sadowski Zygmunt; Budaj Andrzej; López-Sendón Jose L; Guneri Sema; Jiang Frank; White Harvey D; Fox Keith A A; Braunwald Eugene;
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
The New England journal of medicine 2006;354(14):1477-88.
2006: O'Donoghue Michelle; Morrow David A; Sabatine Marc S; Murphy Sabina A; McCabe Carolyn H; Cannon Christopher P; Braunwald Eugene
Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
Circulation 2006;113(14):1745-52.
2006: Wiviott Stephen D; de Lemos James A; Cannon Christopher P; Blazing Michael; Murphy Sabina A; McCabe Carolyn H; Califf Robert; Braunwald Eugene
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Circulation 2006;113(11):1406-14.
2006: Januzzi James L; Newby L Kristin; Murphy Sabina A; Pieper Karen; Antman Elliot M; Morrow David A; Sabatine Marc S; Ohman E Magnus; Cannon Christopher P; Braunwald Eugene
Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
American heart journal 2006;151(2):360-6.
2006: Maisel Alan S; Bhalla Vikas; Braunwald Eugene
Cardiac biomarkers: a contemporary status report.
Nature clinical practice. Cardiovascular medicine 2006;3(1):24-34.
2005: Morrow David A; de Lemos James A; Blazing Michael A; Sabatine Marc S; Murphy Sabina A; Jarolim Petr; White Harvey D; Fox Keith A A; Califf Robert M; Braunwald Eugene;
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
JAMA : the journal of the American Medical Association 2005;294(22):2866-71.
2005: Sabatine Marc S; Morrow David A; Montalescot Gilles; Dellborg Mikael; Leiva-Pons Jose L; Keltai Matyas; Murphy Sabina A; McCabe Carolyn H; Gibson C Michael; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Circulation 2005;112(25):3846-54.
2005: Ranade Koustubh; Kirchgessner Todd G; Iakoubova Olga A; Devlin James J; DelMonte Terrye; Vishnupad Priya; Hui Lester; Tsuchihashi Zenta; Sacks Frank M; Sabatine Marc S; Braunwald Eugene; White Thomas J; Shaw Peter M; Dracopoli Nicholas C
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.
Stroke; a journal of cerebral circulation 2005;36(11):2346-50.
2005: Braunwald Eugene
Cardiology: how did we get here, where are we today and where are we going?
The Canadian journal of cardiology 2005;21(12):1015-7.
2005: Ray Kausik K; Cannon Christopher P; Cairns Richard; Morrow David A; Rifai Nader; Kirtane Ajay J; McCabe Carolyn H; Skene Allan M; Gibson C Michael; Ridker Paul M; Braunwald Eugene;
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Journal of the American College of Cardiology 2005;46(8):1417-24.
2005: Wiviott Stephen D; Cannon Christopher P; Morrow David A; Ray Kausik K; Pfeffer Marc A; Braunwald Eugene;
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
Journal of the American College of Cardiology 2005;46(8):1411-6.
2005: Ray Kausik K; Cannon Christopher P; McCabe Carolyn H; Cairns Richard; Tonkin Andrew M; Sacks Frank M; Jackson Graham; Braunwald Eugene;
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
Journal of the American College of Cardiology 2005;46(8):1405-10.
2005: Skali Hicham; Zornoff Leonardo A M; Pfeffer Marc A; Arnold Malcolm O; Lamas Gervasio A; Moyé Lemuel A; Plappert Ted; Rouleau Jean L; Sussex Bruce A; St John Sutton Martin; Braunwald Eugene; Solomon Scott D;
Prognostic use of echocardiography 1 year after a myocardial infarction.
American heart journal 2005;150(4):743-9.
2005: Sabatine Marc S; Cannon Christopher P; Gibson C Michael; López-Sendón Jose L; Montalescot Gilles; Theroux Pierre; Lewis Basil S; Murphy Sabina A; McCabe Carolyn H; Braunwald Eugene;
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
JAMA : the journal of the American Medical Association 2005;294(10):1224-32.
2005: Giugliano Robert P; Braunwald Eugene
The year in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2005;46(5):906-19.
2005: Moghbeli Nazanin; Kirtane Ajay J; Ray Kausik K; Murphy Sabina A; Gibson C Michael; Braunwald Eugene; Cannon Christopher P;
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).
The American journal of cardiology 2005;96(5):635-8.
2005: Ohman E Magnus; Van de Werf Frans; Antman Elliott M; Califf Robert M; de Lemos James A; Gibson C Michael; Oliverio Renee L; Harrelson Lynn; McCabe Carolyn; DiBattiste Peter; Braunwald Eugene;
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.
American heart journal 2005;150(1):79-88.
2005: Cannon Christopher P; Murphy Sabina A; Braunwald Eugene
Intensive lipid lowering with atorvastatin in coronary disease.
The New England journal of medicine 2005;353(1):93-6; author reply 93-6.
2005: Pinto Duane S; Skolnick Adam H; Kirtane Ajay J; Murphy Sabina A; Barron Hal V; Giugliano Robert P; Cannon Christopher P; Braunwald Eugene; Gibson C Michael;
U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2005;46(1):178-80.
2005: Giugliano Robert P; Newby L Kristin; Harrington Robert A; Gibson C Michael; Van de Werf Frans; Armstrong Paul; Montalescot Gilles; Gilbert James; Strony John T; Califf Robert M; Braunwald Eugene;
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale.
American heart journal 2005;149(6):994-1002.
2005: Wiviott Stephen D; Antman Elliott M; Winters Kenneth J; Weerakkody Govinda; Murphy Sabina A; Behounek Bruce D; Carney Robert J; Lazzam Charles; McKay Raymond G; McCabe Carolyn H; Braunwald Eugene;
Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial.
Circulation 2005;111(25):3366-73.
2005: Mehta Shamir R; Cannon Christopher P; Fox Keith A A; Wallentin Lars; Boden William E; Spacek Rudolf; Widimsky Petr; McCullough Peter A; Hunt David; Braunwald Eugene; Yusuf Salim
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.
JAMA : the journal of the American Medical Association 2005;293(23):2908-17.
2005: Kirtane Ajay J; Leder David M; Waikar Sushrut S; Chertow Glenn M; Ray Kausik K; Pinto Duane S; Karmpaliotis Dimitrios; Burger Andrew J; Murphy Sabina A; Cannon Christopher P; Braunwald Eugene; Gibson C Michael;
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.
Journal of the American College of Cardiology 2005;45(11):1781-6.
2005: Mega Jessica L; Morrow David A; Sabatine Marc S; Zhao Xue-Qiao; Snapinn Steven M; DiBattiste Peter M; Gibson C Michael; Antman Elliott M; Braunwald Eugene; Théroux Pierre
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.
American heart journal 2005;149(5):846-50.
2005: Ridker Paul M; Morrow David A; Rose Lynda M; Rifai Nader; Cannon Christopher P; Braunwald Eugene
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
Journal of the American College of Cardiology 2005;45(10):1644-8.
2005: Cannon Christopher P; Braunwald Eugene; McCabe Carolyn H; Grayston J Thomas; Muhlestein Brent; Giugliano Robert P; Cairns Richard; Skene Allan M;
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
The New England journal of medicine 2005;352(16):1646-54.
2005: Sabatine Marc S; Morrow David A; Giugliano Robert P; Burton Paul B J; Murphy Sabina A; McCabe Carolyn H; Gibson C Michael; Braunwald Eugene
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes.
Circulation 2005;111(16):2042-9.
2005: Giugliano Robert P; Braunwald Eugene;
2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians.
Nature clinical practice. Cardiovascular medicine 2005;2(3):114-5.
2005: Smith Charles S; Cannon Christopher P; McCabe Carolyn H; Murphy Sabina A; Bentley Jane; Braunwald Eugene
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial.
American heart journal 2005;149(3):444-50.
2005: Sabatine Marc S; Cannon Christopher P; Gibson C Michael; López-Sendón Jose L; Montalescot Gilles; Theroux Pierre; Claeys Marc J; Cools Frank; Hill Karen A; Skene Allan M; McCabe Carolyn H; Braunwald Eugene;
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
The New England journal of medicine 2005;352(12):1179-89.
2005: Ray Kausik K; Morrow David A; Gibson C Michael; Murphy Sabina; Antman Elliott M; Braunwald Eugene
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.
European heart journal 2005;26(5):440-6.
2005: Antman Elliott M; Morrow David A; McCabe Carolyn H; Jiang Frank; White Harvey D; Fox Keith A A; Sharma Divakar; Chew Paul; Braunwald Eugene;
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
American heart journal 2005;149(2):217-26.
2005: Gibson C Michael; Kirtane Ajay J; Boundy Keith; Ly Hung; Karmpaliotis Dimitrios; Murphy Sabina A; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.
Journal of the American College of Cardiology 2005;45(3):357-62.
2005: Kirtane Ajay J; Kosmidou Ioanna; Karmpaliotis Dimitrios; Murphy Sabina A; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy.
The American journal of cardiology 2005;95(3):337-42.
2005: Kirtane Ajay J; Martinezclark Pedro; Rahman Aref M; Ray Kausik K; Karmpaliotis Dimitrios; Murphy Sabina A; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Roe Matthew T; Harrington Robert A; Ohman E Magnus; Braunwald Eugene; Gibson C Michael
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2005;45(2):321-3.
2005: Sabatine Marc S; Braunwald Eugene
Another look at the age-old question: which came first, the elevated c-reactive protein or the atherothrombosis?
Journal of the American College of Cardiology 2005;45(2):244-5.
2005: Kirtane Ajay J; Weisbord Aaron; Karmpaliotis Dimitrios; Murphy Sabina A; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Ohman E Magnus; Roe Matthew T; Braunwald Eugene; Gibson C Michael;
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.
The American journal of cardiology 2005;95(2):224-7.
2005: Ridker Paul M; Cannon Christopher P; Morrow David; Rifai Nader; Rose Lynda M; McCabe Carolyn H; Pfeffer Marc A; Braunwald Eugene;
C-reactive protein levels and outcomes after statin therapy.
The New England journal of medicine 2005;352(1):20-8.
2005: Dokainish Hisham; Pillai Manu; Murphy Sabina A; DiBattiste Peter M; Schweiger Marc J; Lotfi Amir; Morrow David A; Cannon Christopher P; Braunwald Eugene; Lakkis Nasser;
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Journal of the American College of Cardiology 2005;45(1):19-24.
2004: Giugliano Robert P; Braunwald Eugene
Baseline troponin in acute coronary syndromes managed invasively.
The American journal of medicine 2004;117(12):963-5.
2004: Tokmakova Mariya P; Skali Hicham; Kenchaiah Satish; Braunwald Eugene; Rouleau Jean L; Packer Milton; Chertow Glenn M; Moyé Lemuel A; Pfeffer Marc A; Solomon Scott D
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Circulation 2004;110(24):3667-73.
2004: Turakhia Minang P; Murphy Sabina A; Pinto Tina L; Antman Elliott M; Giugliano Robert P; Cannon Christopher P; Braunwald Eugene; Gibson C Michael;
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(11):1406-10.
2004: Sabatine Marc S; Morrow David A; de Lemos James A; Omland Torbjorn; Desai Milind Y; Tanasijevic Milenko; Hall Christian; McCabe Carolyn H; Braunwald Eugene
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
Journal of the American College of Cardiology 2004;44(10):1988-95.
2004: Gibson C Michael; Dumaine Raphaelle L; Gelfand Eli V; Murphy Sabina A; Morrow David A; Wiviott Stephen D; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials.
European heart journal 2004;25(22):1998-2005.
2004: Murcia Alvaro M; Hennekens Charles H; Lamas Gervasio A; Jiménez-Navarro Manuel; Rouleau Jean L; Flaker Greg C; Goldman Steven; Skali Hicham; Braunwald Eugene; Pfeffer Marc A
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Archives of internal medicine 2004;164(20):2273-9.
2004: Braunwald Eugene; Domanski Michael J; Fowler Sarah E; Geller Nancy L; Gersh Bernard J; Hsia Judith; Pfeffer Marc A; Rice Madeline M; Rosenberg Yves D; Rouleau Jean L;
Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
The New England journal of medicine 2004;351(20):2058-68.
2004: Karmpaliotis Dimitrios; Turakhia Minang P; Kirtane Ajay J; Murphy Sabina A; Kosmidou Ioanna; Morrow David A; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
The American journal of cardiology 2004;94(9):1113-7.
2004: Buchwald Henry; Avidor Yoav; Braunwald Eugene; Jensen Michael D; Pories Walter; Fahrbach Kyle; Schoelles Karen
Bariatric surgery: a systematic review and meta-analysis.
JAMA : the journal of the American Medical Association 2004;292(14):1724-37.
2004: Kashani Amir; Giugliano Robert P; Antman Elliott M; Morrow David A; Gibson C Michael; Murphy Sabina A; Braunwald Eugene
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction.
European heart journal 2004;25(19):1702-10.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Brady William E; White Harvey D; Fox Keith A A; Palmisano Joanne; Ramsey Karen E; Bilheimer David W; Lewis Eldrin F; Pfeffer M; Califf Robert M; Braunwald Eugene;
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
European heart journal 2004;25(19):1688-94.
2004: Morrow David A; Sabatine Marc S; Antman Elliott M; Cannon Christopher P; Braunwald Eugene; Theroux Pierre
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS).
The American journal of cardiology 2004;94(6):774-6.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Lewis Eldrin F; Fox Keith A A; White Harvey D; Rouleau Jean-Lucien; Pedersen Terje R; Gardner Laura H; Mukherjee Robin; Ramsey Karen E; Palmisano Joanne; Bilheimer David W; Pfeffer Marc A; Califf Robert M; Braunwald Eugene;
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
JAMA : the journal of the American Medical Association 2004;292(11):1307-16.
2004: Gibson C Michael; Murphy Sabina A; Kirtane Ajay J; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(5):980-7.
2004: Sadanandan Saihari; Cannon Christopher P; Chekuri Kasi; Murphy Sabina A; Dibattiste Peter M; Morrow David A; de Lemos James A; Braunwald Eugene; Gibson C Michael
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(3):564-8.
2004: Gibson C Michael; Singh Kanwar P; Murphy Sabina A; DiBattiste Peter M; Demopoulos Laura A; Cannon Christopher P; Braunwald Eugene;
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy).
The American journal of cardiology 2004;94(4):492-4.
2004: Wiviott Stephen D; Braunwald Eugene
Unstable angina and non-ST-segment elevation myocardial infarction: part II. Coronary revascularization, hospital discharge, and post-hospital care.
American family physician 2004;70(3):535-8.
2004: Wiviott Stephen D; Braunwald Eugene
Unstable angina and non-ST-segment elevation myocardial infarction: part I. Initial evaluation and management, and hospital care.
American family physician 2004;70(3):525-32.
2004: Sadanandan Saihari; Cannon Christopher P; Gibson C Michael; Murphy Sabina A; DiBattiste Peter M; Braunwald Eugene;
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(4):799-803.
2004: Wiviott Stephen D; Morrow David A; Frederick Paul D; Giugliano Robert P; Gibson C Michael; McCabe Carolyn H; Cannon Christopher P; Antman Elliott M; Braunwald Eugene
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction.
Journal of the American College of Cardiology 2004;44(4):783-9.
2004: Kenchaiah Satish; Davis Barry R; Braunwald Eugene; Rouleau Jean-Lucien; Dagenais Gilles R; Sussex Bruce; Steingart Richard M; Brown Edward J; Lamas Gervasio A; Gordon David; Bernstein Victoria; Pfeffer Marc A;
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
American heart journal 2004;148(2):356-64.
2004: Gibson C Michael; Murphy Sabina A; Morrow David A; Aroesty Julian M; Gibbons Raymond J; Gourlay Steven G; Barron Hal V; Giugliano Robert P; Antman Elliott M; Braunwald Eugene
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction.
American heart journal 2004;148(2):336-40.
2004: Braunwald Eugene
Happy birthday, GISSI!
American heart journal 2004;148(2):187.
2004: Bach Richard G; Cannon Christopher P; Weintraub William S; DiBattiste Peter M; Demopoulos Laura A; Anderson H Vernon; DeLucca Paul T; Mahoney Elizabeth M; Murphy Sabina A; Braunwald Eugene
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes.
Annals of internal medicine 2004;141(3):186-95.
2004: Gibson C Michael; Jennings Lisa K; Murphy Sabina A; Lorenz David P; Giugliano Robert P; Harrington Robert A; Cholera Shila; Krishnan Rajini; Califf Robert M; Braunwald Eugene;
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy.
Circulation 2004;110(6):679-84.
2004: Mega Jessica L; Morrow David A; De Lemos James A; Sabatine Marc S; Murphy Sabina A; Rifai Nader; Gibson C Michael; Antman Elliott M; Braunwald Eugene
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Journal of the American College of Cardiology 2004;44(2):335-9.
2004: Libby Peter; Willerson James T; Braunwald Eugene
C-reactive protein and coronary heart disease.
The New England journal of medicine 2004;351(3):295-8; author reply 295-8.
2004: Gardner Graham S; Frisch Daniel R; Murphy Sabina A; Kirtane Ajay J; Giugliano Robert P; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.
The American journal of cardiology 2004;94(2):178-81.
2004: Petersen John L; Mahaffey Kenneth W; Hasselblad Vic; Antman Elliott M; Cohen Marc; Goodman Shaun G; Langer Anatoly; Blazing Michael A; Le-Moigne-Amrani Anne; de Lemos James A; Nessel Christopher C; Harrington Robert A; Ferguson James J; Braunwald Eugene; Califf Robert M
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
JAMA : the journal of the American Medical Association 2004;292(1):89-96.
2004: Blazing Michael A; de Lemos James A; White Harvey D; Fox Keith A A; Verheugt Freek W A; Ardissino Diego; DiBattiste Peter M; Palmisano Joanne; Bilheimer David W; Snapinn Steven M; Ramsey Karen E; Gardner Laura H; Hasselblad Vic; Pfeffer Marc A; Lewis Eldrin F; Braunwald Eugene; Califf Robert M;
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: Morrow David A; Antman Elliott M; Murphy Sabina A; Assmann Susan F; Giugliano Robert P; Cannon Christopher P; Michael Gibson C; McCabe Carolyn H; Barron Hal V; Van De Werf Frans; Braunwald Eugene
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies.
European heart journal 2004;25(13):1139-45.
2004: Giugliano Robert P; Sabatine Marc S; Gibson C Michael; Roe Matthew T; Harrington Robert A; Murphy Sabina A; Morrow David A; Antman Elliott M; Braunwald Eugene
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.
The American journal of cardiology 2004;93(11):1362-7, A5-6.
2004: Gibson C Michael; Karha Juhana; Giugliano Robert P; Roe Mathew T; Murphy Sabina A; Harrington Robert A; Green Cindy L; Schweiger Marc J; Miklin Jerry S; Baran Kenneth W; Palmeri Sebastian; Braunwald Eugene; Krucoff Mitchell W;
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.
American heart journal 2004;147(5):847-52.
2004: Gibson C Michael; Karha Juhana; Murphy Sabina A; de Lemos James A; Morrow David A; Giugliano Robert P; Roe Mathew T; Harrington Robert A; Cannon Christopher P; Antman Elliott M; Califf Robert M; Braunwald Eugene;
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.
Journal of the American College of Cardiology 2004;43(7):1170-6.
2004: Cannon Christopher P; Braunwald Eugene; McCabe Carolyn H; Rader Daniel J; Rouleau Jean L; Belder Rene; Joyal Steven V; Hill Karen A; Pfeffer Marc A; Skene Allan M;
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
The New England journal of medicine 2004;350(15):1495-504.
2004: Givertz Michael M; Braunwald Eugene
Neurohormones in heart failure: predicting outcomes, optimizing care.
European heart journal 2004;25(4):281-2.
2004: Wiviott Stephen D; Cannon Christopher P; Morrow David A; Murphy Sabina A; Gibson C Michael; McCabe Carolyn H; Sabatine Marc S; Rifai Nader; Giugliano Robert P; DiBattiste Peter M; Demopoulos Laura A; Antman Elliott M; Braunwald Eugene
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Circulation 2004;109(5):580-6.
2004: Sabatine Marc S; Morrow David A; Giugliano Robert P; Murphy Sabina A; Demopoulos Laura A; DiBattiste Peter M; Weintraub William S; McCabe Carolyn H; Antman Elliott M; Cannon Christopher P; Braunwald Eugene
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Circulation 2004;109(7):874-80.
2003: Braunwald Eugene
The Simon Dack lecture. Cardiology: the past, the present, and the future.
Journal of the American College of Cardiology 2003;42(12):2031-41.
2003: Giugliano Robert P; Braunwald Eugene;
Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time.
Circulation 2003;108(23):2828-30.
2003: Gibson C Michael; Pinto Duane S; Murphy Sabina A; Morrow David A; Hobbach Hans Peter; Wiviott Stephen D; Giugliano Robert P; Cannon Christopher P; Antman Elliott M; Braunwald Eugene;
Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality.
Journal of the American College of Cardiology 2003;42(9):1535-43.
2003: Braunwald Eugene
Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction.
Circulation 2003;108(16 Suppl 1):III28-37.
2003: Lewis Eldrin F; Moye Lemuel A; Rouleau Jean L; Sacks Frank M; Arnold J Malcolm O; Warnica J Wayne; Flaker Greg C; Braunwald Eugene; Pfeffer Marc A;
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.
Journal of the American College of Cardiology 2003;42(8):1446-53.
2003: Karha Juhana; Murphy Sabina A; Kirtane Ajay J; de Lemos James A; Aroesty Julian M; Cannon Christopher P; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.
The American journal of cardiology 2003;92(8):913-8.
2003: Giugliano Robert P; Braunwald Eugene
Improving antithrombotic treatment in patients after myocardial infarction.
Lancet 2003;362(9386):757.
2003: Varo Nerea; de Lemos James A; Libby Peter; Morrow David A; Murphy Sabina A; Nuzzo Rebecca; Gibson C Michael; Cannon Christopher P; Braunwald Eugene; Schönbeck Uwe
Soluble CD40L: risk prediction after acute coronary syndromes.
Circulation 2003;108(9):1049-52.
2003: Morrow David A; Rifai Nader; Sabatine Marc S; Ayanian Shake; Murphy Sabina A; de Lemos James A; Braunwald Eugene; Cannon Christopher P
Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.
Clinical chemistry 2003;49(8):1396-8.
2003: Morrow David A; Braunwald Eugene
Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy.
Circulation 2003;108(3):250-2.
2003: Murphy Sabina A; Dauterman Kent; de Lemos James A; Kermgard Sarah; Antman Elliott M; Braunwald Eugene; Gibson C Michael;
Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial.
American heart journal 2003;146(1):42-7.
2003: Gibson C Michael; Karha Juhana; Murphy Sabina A; James David; Morrow David A; Cannon Christopher P; Giugliano Robert P; Antman Elliott M; Braunwald Eugene;
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.
Journal of the American College of Cardiology 2003;42(1):7-16.
2003: St John Sutton Martin; Lee Douglas; Rouleau Jean Lucien; Goldman Steven; Plappert Ted; Braunwald Eugene; Pfeffer Marc A
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
Circulation 2003;107(20):2577-82.
2003: Morrow David A; de Lemos James A; Sabatine Marc S; Murphy Sabina A; Demopoulos Laura A; DiBattiste Peter M; McCabe Carolyn H; Gibson C Michael; Cannon Christopher P; Braunwald Eugene
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
Journal of the American College of Cardiology 2003;41(8):1264-72.
2003: Giugliano Robert P; Roe Matthew T; Harrington Robert A; Gibson C Michael; Zeymer Uwe; Van de Werf Frans; Baran Kenneth W; Hobbach Hans Peter; Woodlief Lynn H; Hannan Karen L; Greenberg Sally; Miller Joanne; Kitt Michael M; Strony John; McCabe Carolyn H; Braunwald Eugene; Califf Robert M;
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Journal of the American College of Cardiology 2003;41(8):1251-60.
2003: Cotter Gad; Cannon Christopher P; McCabe Carolyn H; Michowitz Yoav; Kaluski Edo; Charlesworth Andrew; Milo Olga; Bentley Jane; Blatt Alex; Krakover Rikardo; Zimlichman Reuven; Reisin Leonardo; Marmor Alon; Lewis Basil; Vered Zvi; Caspi Avi; Braunwald Eugene;
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
American heart journal 2003;145(4):622-7.
2003: Braunwald Eugene
Circulation Research: reflections on the founding editor, Carl J. Wiggers.
Circulation research 2003;92(3):253-4.
2003: de Lemos James A; Morrow David A; Sabatine Marc S; Murphy Sabina A; Gibson C Michael; Antman Elliott M; McCabe Carolyn H; Cannon Christopher P; Braunwald Eugene
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
Circulation 2003;107(5):690-5.
2003: Bahit Maria Cecilia; Cannon Christopher P; Antman Elliott M; Murphy Sabina A; Gibson C Michael; McCabe Carolyn H; Braunwald Eugene;
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry.
American heart journal 2003;145(1):109-17.
2002: Weber Jim Edward; Hollander Judd E; Murphy Sabina A; Braunwald Eugene; Gibson C Michael
Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use.
Journal of thrombosis and thrombolysis 2002;14(3):239-45.
2002: Glaser Ruchira; Herrmann Howard C; Murphy Sabina A; Demopoulos Laura A; DiBattiste Peter M; Cannon Christopher P; Braunwald Eugene
Benefit of an early invasive management strategy in women with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;288(24):3124-9.
2002: Januzzi James L; Cannon Christopher P; DiBattiste Peter M; Murphy Sabina; Weintraub William; Braunwald Eugene;
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial).
The American journal of cardiology 2002;90(11):1246-9.
2002: Braunwald Eugene
Personal reflections on efforts to reduce ischemic myocardial damage.
Cardiovascular research 2002;56(3):332-8.
2002: Sabatine Marc S; Morrow David A; Cannon Christopher P; Murphy Sabina A; Demopoulos Laura A; DiBattiste Peter M; McCabe Carolyn H; Braunwald Eugene; Gibson C Michael
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Journal of the American College of Cardiology 2002;40(10):1761-8.
2002: Sharis Peter J; Cannon Christopher P; Rogers William J; McCabe Carolyn; Murphy Sabina; Gibson C Michael; Stone Peter H; Braunwald Eugene
Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry).
The American journal of cardiology 2002;90(10):1154-6.
2002: Cooper Howard A; de Lemos James A; Morrow David A; Sabatine Marc S; Murphy Sabina A; McCabe Carolyn H; Gibson C Michael; Antman Elliott M; Braunwald Eugene
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration.
American heart journal 2002;144(5):790-5.
2002: Moses Hamilton; Braunwald Eugene; Martin Joseph B; Thier Samuel O
Collaborating with industry--choices for the academic medical center.
The New England journal of medicine 2002;347(17):1371-5.
2002: Braunwald Eugene
Hypertrophic cardiomyopathy--the benefits of a multidisciplinary approach.
The New England journal of medicine 2002;347(17):1306-7.
2002: Braunwald Eugene; Antman Elliott M; Beasley John W; Califf Robert M; Cheitlin Melvin D; Hochman Judith S; Jones Robert H; Kereiakes Dean; Kupersmith Joel; Levin Thomas N; Pepine Carl J; Schaeffer John W; Smith Earl E; Steward David E; Theroux Pierre; Gibbons Raymond J; Alpert Joseph S; Faxon David P; Fuster Valentin; Gregoratos Gabriel; Hiratzka Loren F; Jacobs Alice K; Smith Sidney C;
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2002;40(7):1366-74.
2002: Scirica Benjamin M; Cannon Christopher P; McCabe Carolyn H; Murphy Sabina A; Anderson H Vernon; Rogers William J; Stone Peter H; Braunwald Eugene;
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification.
The American journal of cardiology 2002;90(8):821-6.
2002: Angeja Brad G; de Lemos James; Murphy Sabina A; Marble Susan J; Antman Elliott M; Cannon Christopher P; Braunwald Eugene; Gibson C Michael;
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy.
American heart journal 2002;144(4):649-56.
2002: Braunwald Eugene; Antman Elliott M; Beasley John W; Califf Robert M; Cheitlin Melvin D; Hochman Judith S; Jones Robert H; Kereiakes Dean; Kupersmith Joel; Levin Thomas N; Pepine Carl J; Schaeffer John W; Smith Earl E; Steward David E; Theroux Pierre; Gibbons Raymond J; Alpert Joseph S; Faxon David P; Fuster Valentin; Gregoratos Gabriel; Hiratzka Loren F; Jacobs Alice K; Smith Sidney C;
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Circulation 2002;106(14):1893-900.
2002: Kleiman Neal S; Lakkis Nasser; Cannon Christopher P; Murphy Sabina A; DiBattiste Peter M; Demopoulos Laura A; Weintraub William S; Braunwald Eugene;
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.
Journal of the American College of Cardiology 2002;40(6):1044-50.
2002: Braunwald Eugene; Seidman Christine E; Sigwart Ulrich
Contemporary evaluation and management of hypertrophic cardiomyopathy.
Circulation 2002;106(11):1312-6.
2002: Solomon Scott D; St John Sutton Martin; Lamas Gervasio A; Plappert Ted; Rouleau Jean L; Skali Hicham; Moyé Lemuel; Braunwald Eugene; Pfeffer Marc A;
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction.
Circulation 2002;106(10):1251-5.
2002: Scirica Benjamin M; Cannon Christopher P; Antman Elliott M; Murphy Sabina A; Morrow David A; Sabatine Marc S; McCabe Carolyn H; Gibson C Michael; Braunwald Eugene
Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry.
The American journal of cardiology 2002;90(3):303-5.
2002: de Lemos James A; Morrow David A; Gibson C Michael; Murphy Sabina A; Sabatine Marc S; Rifai Nader; McCabe Carolyn H; Antman Elliott M; Cannon Christopher P; Braunwald Eugene
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.
Journal of the American College of Cardiology 2002;40(2):238-44.
2002: Morrow David A; Antman Elliott M; Sayah Assaad; Schuhwerk Kristin C; Giugliano Robert P; deLemos James A; Waller Michael; Cohen Sidney A; Rosenberg Donald G; Cutler Sally S; McCabe Carolyn H; Walls Ron M; Braunwald Eugene
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.
Journal of the American College of Cardiology 2002;40(1):71-7.
2002: Angeja Brad G; Kermgard Sarah; Chen Michael S; McKay Matthew; Murphy Sabina A; Antman Elliott M; Cannon Christopher P; Braunwald Eugene; Gibson C Michael
The smoker's paradox: insights from the angiographic substudies of the TIMI trials.
Journal of thrombosis and thrombolysis 2002;13(3):133-9.
2002: Sabatine Marc S; McCabe Carolyn H; Morrow David A; Giugliano Robert P; de Lemos James A; Cohen Marc; Antman Elliott M; Braunwald Eugene
Identification of patients at high risk for death and cardiac ischemic events after hospital discharge.
American heart journal 2002;143(6):966-70.
2002: Michels Karin B; Braunwald Eugene
Estimating treatment effects from observational data: dissonant and resonant notes from the SYMPHONY trials.
JAMA : the journal of the American Medical Association 2002;287(23):3130-2.
2002: Antman E M; Cooper H A; Gibson C M; de Lemos J A; McCabe C H; Giugliano R P; Coussement P; Murphy S; Scherer J; Anderson K; Van de Werf F; Braunwald E;
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II.
European heart journal 2002;23(12):928-33.
2002: Pfeffer Marc A; Keech Anthony; Sacks Frank M; Cobbe Stuart M; Tonkin Andrew; Byington Robert P; Davis Barry R; Friedman Carola P; Braunwald Eugene
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project.
Circulation 2002;105(20):2341-6.
2002: Zornoff Leonardo A M; Skali Hicham; Pfeffer Marc A; St John Sutton Martin; Rouleau Jean L; Lamas Gervasio A; Plappert Ted; Rouleau Jacques R; Moyé Lemuel A; Lewis Sandra J; Braunwald Eugene; Solomon Scott D;
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction.
Journal of the American College of Cardiology 2002;39(9):1450-5.
2002: Gibson C Michael; Cannon Christopher P; Murphy Sabina A; Marble Susan J; Barron Hal V; Braunwald Eugene;
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction.
Circulation 2002;105(16):1909-13.
2002: Sabatine Marc S; Morrow David A; de Lemos James A; Gibson C Michael; Murphy Sabina A; Rifai Nader; McCabe Carolyn; Antman Elliott M; Cannon Christopher P; Braunwald Eugene
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
Circulation 2002;105(15):1760-3.
2002: Antman Elliott M; Louwerenburg Hans W; Baars Hubert F; Wesdorp Jan C L; Hamer Bas; Bassand Jean-Pierre; Bigonzi Frederique; Pisapia Ghislaine; Gibson C Michael; Heidbuchel Hein; Braunwald Eugene; Van de Werf Frans
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Circulation 2002;105(14):1642-9.
2002: Cannon Christopher P; McCabe Carolyn H; Belder Rene; Breen Jeanne; Braunwald Eugene
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
The American journal of cardiology 2002;89(7):860-1.
2002: Braunwald Eugene
Letter from Eugene Braunwald.
Critical pathways in cardiology 2002;1(1):A1.
2002: Sacks Frank M; Tonkin Andrew M; Craven Timothy; Pfeffer Marc A; Shepherd James; Keech Anthony; Furberg Curt D; Braunwald Eugene
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
Circulation 2002;105(12):1424-8.
2002: Omland Torbjørn; de Lemos James A; Morrow David A; Antman Elliot M; Cannon Christopher P; Hall Christian; Braunwald Eugene
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.
The American journal of cardiology 2002;89(4):463-5.
2002: Antman Elliott M; McCabe Carolyn H; Braunwald Eugene
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
American heart journal 2002;143(2):229-34.
2002: Antman E M; Cohen M; McCabe C; Goodman S G; Murphy S A; Braunwald E;
Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.
European heart journal 2002;23(4):308-14.
2002: Morrow D A; Antman E M; Snapinn S M; McCabe C H; Theroux P; Braunwald E
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
European heart journal 2002;23(3):223-9.
2001: Morrow D A; Antman E M; Giugliano R P; Cairns R; Charlesworth A; Murphy S A; de Lemos J A; McCabe C H; Braunwald E
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.
Lancet 2001;358(9293):1571-5.
2001: Morrow D A; Cannon C P; Rifai N; Frey M J; Vicari R; Lakkis N; Robertson D H; Hille D A; DeLucca P T; DiBattiste P M; Demopoulos L A; Weintraub W S; Braunwald E;
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.
JAMA : the journal of the American Medical Association 2001;286(19):2405-12.
2001: de Lemos J A; Braunwald E
ST segment resolution as a tool for assessing the efficacy of reperfusion therapy.
Journal of the American College of Cardiology 2001;38(5):1283-94.
2001: Llevadot J; Giugliano R P; Antman E M; Wilcox R G; Gurfinkel E P; Henry T; McCabe C H; Charlesworth A; Thompson S; Nicolau J C; Tebbe U; Sadowski Z; Braunwald E;
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.
European heart journal 2001;22(22):2104-15.
2001: de Lemos J A; Morrow D A; Bentley J H; Omland T; Sabatine M S; McCabe C H; Hall C; Cannon C P; Braunwald E
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
The New England journal of medicine 2001;345(14):1014-21.
2001: Morrow D A; Antman E M; Parsons L; de Lemos J A; Cannon C P; Giugliano R P; McCabe C H; Barron H V; Braunwald E
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.
JAMA : the journal of the American Medical Association 2001;286(11):1356-9.
2001: Pfeffer M A; Domanski M; Verter J; Dunlap M; Flaker G C; Gersh B; Hsia J; Goldberg A D; Limacher M C; Maggioni A P; Rosenberg Y; Rouleau J L; Warnica J W; Wasserman A G; Braunwald E;
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial.
American heart journal 2001;142(3):375-7.
2001: Giugliano R P; Llevadot J; Wilcox R G; Gurfinkel E P; McCabe C H; Charlesworth A; Thompson S L; Antman E M; Braunwald E;
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.
European heart journal 2001;22(18):1702-15.
2001: de Lemos J A; Morrow D A; Gibson C M; Murphy S A; Rifai N; Tanasijevic M; Giugliano R P; Schuhwerk K C; McCabe C H; Cannon C P; Antman E M; Braunwald E;
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.
The American journal of cardiology 2001;88(4):353-8.
2001: Bray P F; Cannon C P; Goldschmidt-Clermont P; Moyé L A; Pfeffer M A; Sacks F M; Braunwald E
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
The American journal of cardiology 2001;88(4):347-52.
2001: Cooper H A; Braunwald E
Clinical importance of stunned and hibernating myocardium.
Coronary artery disease 2001;12(5):387-92.
2001: Blazing M A; De Lemos J A; Dyke C K; Califf R M; Bilheimer D; Braunwald E
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy.
American heart journal 2001;142(2):211-7.
2001: Cannon C P; Weintraub W S; Demopoulos L A; Vicari R; Frey M J; Lakkis N; Neumann F J; Robertson D H; DeLucca P T; DiBattiste P M; Gibson C M; Braunwald E;
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
The New England journal of medicine 2001;344(25):1879-87.
2001: Braunwald E
The Denolin lecture. Congestive heart failure: a half century perspective.
European heart journal 2001;22(10):825-36.
2001: Giugliano R P; McCabe C H; Antman E M; Cannon C P; Van de Werf F; Wilcox R G; Braunwald E;
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
American heart journal 2001;141(5):742-50.
2001: Holper E M; Antman E M; McCabe C H; Premmereur J; Gurfinkel E; Bernink P J; Turpie A G; Bayes de Luna A; Lablanche J M; Fox K M; Salein D; Radley D R; Braunwald E
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
The American journal of cardiology 2001;87(8):1008-10; A5.
2001: de Lemos J A; Gibson C M; Antman E M; Murphy S A; Morrow D A; Schuhwerk K C; Schweiger M; Coussement P; Van de Werf F; Braunwald E;
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
American heart journal 2001;141(4):592-8.
2001: Cannon C P; McCabe C H; Wilcox R G; Bentley J H; Braunwald E
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators.
The American journal of cardiology 2001;87(5):636-9, A10.
2001: Braunwald E
Nina Starr Braunwald: some reflections on the first woman heart surgeon.
The Annals of thoracic surgery 2001;71(2 Suppl):S6-7.
2001: Wang-Clow F; Fox N L; Cannon C P; Gibson C M; Berioli S; Bluhmki E; Danays T; Braunwald E; Van De Werf F; Stump D C
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator.
American heart journal 2001;141(1):33-40.
2000: Gibson C M; Anshelevich M; Murphy S; Luu L; Hynes C; Kliris J; Kermgard S; Otten M H; Antman E M; Cannon C P; Braunwald E;
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
The American journal of cardiology 2000;86(12):1378-9, A5.
2000: de Lemos J A; Antman E M; Giugliano R P; Morrow D A; McCabe C H; Cutler S S; Charlesworth A; Schröder R; Braunwald E
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.
The American journal of cardiology 2000;86(11):1235-7, A5.
2000: Antman E M; Gibson C M; de Lemos J A; Giugliano R P; McCabe C H; Coussement P; Menown I; Nienaber C A; Rehders T C; Frey M J; Van der Wieken R; Andresen D; Scherer J; Anderson K; Van de Werf F; Braunwald E
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
European heart journal 2000;21(23):1944-53.
2000: Morrow D A; Antman E M; Tanasijevic M; Rifai N; de Lemos J A; McCabe C H; Cannon C P; Braunwald E
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.
Journal of the American College of Cardiology 2000;36(6):1812-7.
2000: Braunwald E; Bristow M R
Congestive heart failure: fifty years of progress.
Circulation 2000;102(20 Suppl 4):IV14-23.
2000: Barron H V; Cannon C P; Murphy S A; Braunwald E; Gibson C M
Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy.
Circulation 2000;102(19):2329-34.
2000: Morrow D A; Antman E M; Charlesworth A; Cairns R; Murphy S A; de Lemos J A; Giugliano R P; McCabe C H; Braunwald E
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.
Circulation 2000;102(17):2031-7.
2000: Sacks F M; Tonkin A M; Shepherd J; Braunwald E; Cobbe S; Hawkins C M; Keech A; Packard C; Simes J; Byington R; Furberg C D
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.
Circulation 2000;102(16):1893-900.
2000: Sacks F M; Alaupovic P; Moye L A; Cole T G; Sussex B; Stampfer M J; Pfeffer M A; Braunwald E
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
Circulation 2000;102(16):1886-92.
2000: Braunwald E; Antman E M; Beasley J W; Califf R M; Cheitlin M D; Hochman J S; Jones R H; Kereiakes D; Kupersmith J; Levin T N; Pepine C J; Schaeffer J W; Smith E E; Steward D E; Theroux P; Alpert J S; Eagle K A; Faxon D P; Fuster V; Gardner T J; Gregoratos G; Russell R O; Smith S C
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology 2000;36(3):970-1062.
2000: Braunwald E; Antman E M; Beasley J W; Califf R M; Cheitlin M D; Hochman J S; Jones R H; Kereiakes D; Kupersmith J; Levin T N; Pepine C J; Schaeffer J W; Smith E E; Steward D E; Theroux P; Gibbons R J; Alpert J S; Eagle K A; Faxon D P; Fuster V; Gardner T J; Gregoratos G; Russell R O; Smith S C
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
Circulation 2000;102(10):1193-209.
2000: De Lemos J A; Antman E M; Giugliano R P; Morrow D A; McCabe C H; Charlesworth A; Schröder R; Braunwald E
Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram.
American heart journal 2000;140(3):373-8.
2000: Antman E M; Cohen M; Bernink P J; McCabe C H; Horacek T; Papuchis G; Mautner B; Corbalan R; Radley D; Braunwald E
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.
JAMA : the journal of the American Medical Association 2000;284(7):835-42.
2000: Cannon C P; McCabe C H; Wilcox R G; Langer A; Caspi A; Berink P; Lopez-Sendon J; Toman J; Charlesworth A; Anders R J; Alexander J C; Skene A; Braunwald E
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.
Circulation 2000;102(2):149-56.
2000: Giugliano R P; McCabe C H; Sequeira R F; Frey M J; Henry T D; Piana R N; Tamby J F; Jensen B K; Nicolas S B; Jennings L K; Wise R J; Braunwald E
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials.
American heart journal 2000;140(1):81-93.
2000: Coulter S A; Cannon C P; Ault K A; Antman E M; Van de Werf F; Adgey A A; Gibson C M; Giugliano R P; Mascelli M A; Scherer J; Barnathan E S; Braunwald E; Kleiman N S
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
Circulation 2000;101(23):2690-5.
2000: Flather M D; Yusuf S; Køber L; Pfeffer M; Hall A; Murray G; Torp-Pedersen C; Ball S; Pogue J; Moyé L; Braunwald E
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
Lancet 2000;355(9215):1575-81.
2000: Modi N B; Fox N L; Clow F W; Tanswell P; Cannon C P; Van de Werf F; Braunwald E
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction.
Journal of clinical pharmacology 2000;40(5):508-15.
2000: de Lemos J A; Antman E M; Giugliano R P; McCabe C H; Murphy S A; Van de Werf F; Gibson C M; Braunwald E
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.
The American journal of cardiology 2000;85(3):299-304.
2000: Morrow D A; Rifai N; Antman E M; Weiner D L; McCabe C H; Cannon C P; Braunwald E
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.
Journal of the American College of Cardiology 2000;35(2):358-62.
2000: Braunwald E; Califf R M; Cannon C P; Fox K A; Fuster V; Gibler W B; Harrington R A; King S B; Kleiman N S; Theroux P; Topol E J; Van de Werf F; White H D; Willerson J T
Redefining medical treatment in the management of unstable angina.
The American journal of medicine 2000;108(1):41-53.
2000: de Lemos J A; Antman E M; Gibson C M; McCabe C H; Giugliano R P; Murphy S A; Coulter S A; Anderson K; Scherer J; Frey M J; Van Der Wieken R; Van De Werf F; Braunwald E
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.
Circulation 2000;101(3):239-43.
2000: Gibson C M; Cannon C P; Murphy S A; Ryan K A; Mesley R; Marble S J; McCabe C H; Van De Werf F; Braunwald E
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.
Circulation 2000;101(2):125-30.
1999: Gibson C M; Cannon C P; Murphy S A; Adgey A A; Schweiger M J; Sequeira R F; Grollier G; Fox N L; Berioli S; Weaver W D; Van de Werf F; Braunwald E
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.
The American journal of cardiology 1999;84(9):976-80.
1999: Gibson C M; Murphy S; Menown I B; Sequeira R F; Greene R; Van de Werf F; Schweiger M J; Ghali M; Frey M J; Ryan K A; Marble S J; Giugliano R P; Antman E M; Cannon C P; Braunwald E
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1999;34(5):1403-12.
1999: Gibson C M; Ryan K A; Murphy S A; Mesley R; Marble S J; Giugliano R P; Cannon C P; Antman E M; Braunwald E
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
Journal of the American College of Cardiology 1999;34(4):974-82.
1999: Antman E M; Cohen M; Radley D; McCabe C; Rush J; Premmereur J; Braunwald E
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.
Circulation 1999;100(15):1602-8.
1999: Antman E M; McCabe C H; Gurfinkel E P; Turpie A G; Bernink P J; Salein D; Bayes De Luna A; Fox K; Lablanche J M; Radley D; Premmereur J; Braunwald E
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Circulation 1999;100(15):1593-601.
1999: Tanasijevic M J; Cannon C P; Antman E M; Wybenga D R; Fischer G A; Grudzien C; Gibson C M; Winkelman J W; Braunwald E
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
Journal of the American College of Cardiology 1999;34(3):739-47.
1999: Stone P H; Thompson B; Zaret B L; Chaitman B; Gibson R S; Schweiger M J; Steingart R; Kirshenbaum J; Thompson C; Fung A; McCabe C H; Knatterud G L; Braunwald E
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.
European heart journal 1999;20(15):1084-93.
1999: Ridker P M; Rifai N; Pfeffer M A; Sacks F; Braunwald E
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.
Circulation 1999;100(3):230-5.
1999: Flaker G C; Warnica J W; Sacks F M; Moyé L A; Davis B R; Rouleau J L; Webel R R; Pfeffer M A; Braunwald E
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators.
Journal of the American College of Cardiology 1999;34(1):106-12.
1999: Antman E M; Giugliano R P; Gibson C M; McCabe C H; Coussement P; Kleiman N S; Vahanian A; Adgey A A; Menown I; Rupprecht H J; Van der Wieken R; Ducas J; Scherer J; Anderson K; Van de Werf F; Braunwald E
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Circulation 1999;99(21):2720-32.
1999: Van de Werf F; Cannon C P; Luyten A; Houbracken K; McCabe C H; Berioli S; Bluhmki E; Sarelin H; Wang-Clow F; Fox N L; Braunwald E
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.
American heart journal 1999;137(5):786-91.
1999: Gibson C M; Murphy S A; Rizzo M J; Ryan K A; Marble S J; McCabe C H; Cannon C P; Van de Werf F; Braunwald E
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.
Circulation 1999;99(15):1945-50.
1999: Pfeffer M A; Sacks F M; Moyé L A; East C; Goldman S; Nash D T; Rouleau J R; Rouleau J L; Sussex B A; Theroux P; Vanden Belt R J; Braunwald E
Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.
Journal of the American College of Cardiology 1999;33(1):125-30.
1999: Plehn J F; Davis B R; Sacks F M; Rouleau J L; Pfeffer M A; Bernstein V; Cuddy T E; Moyé L A; Piller L B; Rutherford J; Simpson L M; Braunwald E
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.
Circulation 1999;99(2):216-23.
1998: Cannon C P; Gibson C M; McCabe C H; Adgey A A; Schweiger M J; Sequeira R F; Grollier G; Giugliano R P; Frey M; Mueller H S; Steingart R M; Weaver W D; Van de Werf F; Braunwald E
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
Circulation 1998;98(25):2805-14.
1998: Braunwald E
Evolution of the management of acute myocardial infarction: a 20th century saga.
Lancet 1998;352(9142):1771-4.
1998: Lewis S J; Moye L A; Sacks F M; Johnstone D E; Timmis G; Mitchell J; Limacher M; Kell S; Glasser S P; Grant J; Davis B R; Pfeffer M A; Braunwald E
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
Annals of internal medicine 1998;129(9):681-9.
1998: Cannon C P; Weintraub W S; Demopoulos L A; Robertson D H; Gormley G J; Braunwald E
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
The American journal of cardiology 1998;82(6):731-6.
1998: Ridker P M; Rifai N; Pfeffer M A; Sacks F M; Moye L A; Goldman S; Flaker G C; Braunwald E
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.
Circulation 1998;98(9):839-44.
1998: Pfeffer M A; Domanski M; Rosenberg Y; Verter J; Geller N; Albert P; Hsia J; Braunwald E
Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition.
The American journal of cardiology 1998;82(3A):25H-30H.
1998: Lewis S J; Sacks F M; Mitchell J S; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye L A; Rouleau J L; Pfeffer M A; Braunwald E
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
Journal of the American College of Cardiology 1998;32(1):140-6.
1998: Braunwald E
The emerging role of low-molecular-weight heparins in cardiology practice. Introduction.
American heart journal 1998;135(6 Pt 3 Su):S327-8.
1998: Morrow D A; Rifai N; Antman E M; Weiner D L; McCabe C H; Cannon C P; Braunwald E
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.
Journal of the American College of Cardiology 1998;31(7):1460-5.
1998: Braunwald E; Maseri A; Armstrong P W; Califf R M; Gibler W B; Hamm C W; Simoons M L; Van de Werf F
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
European heart journal 1998;19 Suppl D():D22-30.
1998: Sacks F M; Moyé L A; Davis B R; Cole T G; Rouleau J L; Nash D T; Pfeffer M A; Braunwald E
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.
Circulation 1998;97(15):1446-52.
1998: Braunwald E; Maseri A; Armstrong P W; Califf R M; Gibler W B; Hamm C W; Simoons M L; Van de Werf F
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
American heart journal 1998;135(4):S56-66.
1998: Cannon C P; McCabe C H; Borzak S; Henry T D; Tischler M D; Mueller H S; Feldman R; Palmeri S T; Ault K; Hamilton S A; Rothman J M; Novotny W F; Braunwald E
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction.
Circulation 1998;97(4):340-9.
1998: Antman E M; Sacks D B; Rifai N; McCabe C H; Cannon C P; Braunwald E
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy.
Journal of the American College of Cardiology 1998;31(2):326-30.
1997: Mitchell G F; Moyé L A; Braunwald E; Rouleau J L; Bernstein V; Geltman E M; Flaker G C; Pfeffer M A
Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement.
Circulation 1997;96(12):4254-60.
1997: St John Sutton M; Pfeffer M A; Moye L; Plappert T; Rouleau J L; Lamas G; Rouleau J; Parker J O; Arnold M O; Sussex B; Braunwald E
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
Circulation 1997;96(10):3294-9.
1997: Tanasijevic M J; Cannon C P; Wybenga D R; Fischer G A; Grudzien C; Gibson C M; Winkelman J W; Antman E M; Braunwald E
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
American heart journal 1997;134(4):622-30.
1997: Cannon C P; Sharis P J; Schweiger M J; McCabe C H; Diver D J; Shah P K; Sequeira R F; Greene R M; Perritt R L; Poole W K; Braunwald E
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction.
The American journal of cardiology 1997;80(6):696-9.
1997: Cannon C P; McCabe C H; Stone P H; Rogers W J; Schactman M; Thompson B W; Pearce D J; Diver D J; Kells C; Feldman T; Williams M; Gibson R S; Kronenberg M W; Ganz L I; Anderson H V; Braunwald E
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia.
Journal of the American College of Cardiology 1997;30(1):133-40.
1997: Gibson C M; Cannon C P; Greene R M; Sequeira R F; Margorien R D; Leya F; Diver D J; Baim D S; Braunwald E
Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial.
The American journal of cardiology 1997;80(1):21-6.
1997: Bovill E G; Tracy R P; Knatterud G L; Stone P H; Nasmith J; Gore J M; Thompson B W; Tofler G H; Kleiman N S; Cannon C; Braunwald E
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
The American journal of cardiology 1997;79(4):391-6.
1997: Cannon C P; McCabe C H; Stone P H; Schactman M; Thompson B; Theroux P; Gibson R S; Feldman T; Kleiman N S; Tofler G H; Muller J E; Chaitman B R; Braunwald E
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).
The American journal of cardiology 1997;79(3):253-8.
1997: Cannon C P; McCabe C H; Gibson C M; Ghali M; Sequeira R F; McKendall G R; Breed J; Modi N B; Fox N L; Tracy R P; Love T W; Braunwald E
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.
Circulation 1997;95(2):351-6.
1996: Williams D O; Braunwald E; Thompson B; Sharaf B L; Buller C E; Knatterud G L
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial.
Circulation 1996;94(11):2749-55.
1996: Antman E M; Tanasijevic M J; Thompson B; Schactman M; McCabe C H; Cannon C P; Fischer G A; Fung A Y; Thompson C; Wybenga D; Braunwald E
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.
The New England journal of medicine 1996;335(18):1342-9.
1996: Sacks F M; Pfeffer M A; Moye L A; Rouleau J L; Rutherford J D; Cole T G; Brown L; Warnica J W; Arnold J M; Wun C C; Davis B R; Braunwald E
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
The New England journal of medicine 1996;335(14):1001-9.
1996: Birnbaum Y; Kloner R A; Sclarovsky S; Cannon C P; McCabe C H; Davis V G; Zaret B L; Wackers F J; Braunwald E
Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial).
The American journal of cardiology 1996;78(4):396-403.
1996: Stone P H; Thompson B; Anderson H V; Kronenberg M W; Gibson R S; Rogers W J; Diver D J; Théroux P; Warnica J W; Nasmith J B; Kells C; Kleiman N; McCabe C H; Schactman M; Knatterud G L; Braunwald E
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.
JAMA : the journal of the American Medical Association 1996;275(14):1104-12.
1996: Becker R C; Cannon C P; Tracy R P; Thompson B; Bovill E G; Desvigne-Nickens P; Randall A M; Knatternud G; Braunwald E
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
American heart journal 1996;131(3):421-33.
1996: Gibson C M; Cannon C P; Daley W L; Dodge J T; Alexander B; Marble S J; McCabe C H; Raymond L; Fortin T; Poole W K; Braunwald E
TIMI frame count: a quantitative method of assessing coronary artery flow.
Circulation 1996;93(5):879-88.
1995: McKendall G R; Forman S; Sopko G; Braunwald E; Williams D O
Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators.
The American journal of cardiology 1995;76(16):1108-11.
1995: Mueller H S; Forman S A; Menegus M A; Cohen L S; Knatterud G L; Braunwald E
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Journal of the American College of Cardiology 1995;26(4):900-7.
1995: Zaret B L; Wackers F J; Terrin M L; Forman S A; Williams D O; Knatterud G L; Braunwald E
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group.
Journal of the American College of Cardiology 1995;26(1):73-9.
1995: Cannon C P; Braunwald E
Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
Journal of the American College of Cardiology 1995;25(7 Suppl):30S-37S.
1995: Cannon C P; Thompson B; McCabe C H; Mueller H S; Kirshenbaum J M; Herson S; Nasmith J B; Chaitman B R; Braunwald E
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials.
The American journal of cardiology 1995;75(15):977-81.
1995: Cannon C P; Braunwald E; McCabe C H; Antman E M
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.
Journal of interventional cardiology 1995;8(2):117-35.
1995: Gersh B J; Chesebro J H; Braunwald E; Lambrew C; Passamani E; Solomon R E; Ross A M; Ross R; Terrin M L; Knatterud G L
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).
Journal of the American College of Cardiology 1995;25(2):395-402.
1994: Braunwald E; Jones R H; Mark D B; Brown J; Brown L; Cheitlin M D; Concannon C A; Cowan M; Edwards C; Fuster V
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.
Circulation 1994;90(1):613-22.
1994: Becker R C; Terrin M; Ross R; Knatterud G L; Desvigne-Nickens P; Gore J M; Braunwald E
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
Annals of internal medicine 1994;120(8):638-45.
1993: Braunwald E; Cannon C P; McCabe C H
Use of composite endpoints in thrombolysis trials of acute myocardial infarction.
The American journal of cardiology 1993;72(19):3G-12G.
1993: Braunwald E
Cardiology--division or department?
The New England journal of medicine 1993;329(25):1887-90.
1993: Terrin M L; Williams D O; Kleiman N S; Willerson J; Mueller H S; Desvigne-Nickens P; Forman S A; Knatterud G L; Braunwald E
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
Journal of the American College of Cardiology 1993;22(7):1763-72.
1993: Kim C B; Braunwald E
Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis.
Circulation 1993;88(5 Pt 1):2426-36.
1993: Ahmed W H; Bittl J A; Braunwald E
Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina.
The American journal of cardiology 1993;72(7):544-50.
1993: Tofler G H; Muller J E; Stone P H; Davies G; Davis V G; Braunwald E
Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS).
The American journal of cardiology 1993;71(12):1031-5.
1993: Cannon C P; Maraganore J M; Loscalzo J; McAllister A; Eddings K; George D; Selwyn A P; Adelman B; Fox I; Braunwald E
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
The American journal of cardiology 1993;71(10):778-82.
1992: Tofler G H; Muller J E; Stone P H; Forman S; Solomon R E; Knatterud G L; Braunwald E
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.
Journal of the American College of Cardiology 1992;20(5):1049-55.
1992: Pfeffer M A; Braunwald E; Moyé L A; Basta L; Brown E J; Cuddy T E; Davis B R; Geltman E M; Goldman S; Flaker G C
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
The New England journal of medicine 1992;327(10):669-77.
1992: Braunwald E; Cannon C P; McCabe C H
An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point.
Circulation 1992;86(2):683-7.
1992: Lamas G A; Pfeffer M A; Hamm P; Wertheimer J; Rouleau J L; Braunwald E
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
The New England journal of medicine 1992;327(4):241-7.
1992: Mueller H S; Cohen L S; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Circulation 1992;85(4):1254-64.
1992: Williams D O; Braunwald E; Knatterud G; Babb J; Bresnahan J; Greenberg M A; Raizner A; Wasserman A; Robertson T; Ross R
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.
Circulation 1992;85(2):533-42.
1991: Kirshenbaum J M; Bahr R D; Flaherty J T; Gurewich V; Levine H J; Loscalzo J; Schumacher R R; Topol E J; Wahr D W; Braunwald E
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
The American journal of cardiology 1991;68(17):1564-9.
1991: Sacks F M; Pfeffer M A; Moye' L; Brown L E; Hamm P; Cole T G; Hawkins C M; Braunwald E
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)
The American journal of cardiology 1991;68(15):1436-46.
1991: Lamas G A; Pfeffer M A; Braunwald E
Patency of the infarct-related coronary artery and ventricular geometry.
The American journal of cardiology 1991;68(14):41D-51D.
1991: Pfeffer M A; Braunwald E
Ventricular enlargement following infarction is a modifiable process.
The American journal of cardiology 1991;68(14):127D-131D.
1991: Braunwald E; Pfeffer M A
Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management.
The American journal of cardiology 1991;68(14):1D-6D.
1991: Pfeffer M A; Moyé L A; Braunwald E; Basta L; Brown E J; Cuddy T E; Dagenais G R; Flaker G O; Geltman E M; Gersh B J
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators.
JAMA : the journal of the American Medical Association 1991;266(4):528-32.
1991: Braunwald E
Intravenous milrinone: therapeutic responses in heart failure.
American heart journal 1991;121(6 Pt 2):1937-8.
1991: Dzau V; Braunwald E
Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement.
American heart journal 1991;121(4 Pt 1):1244-63.
1991: Braunwald E
Subspecialists and internal medicine: a perspective.
Annals of internal medicine 1991;114(1):76-8.
1990: Feit F; Mueller H S; Braunwald E; Ross R; Hodges M; Herman M V; Knatterud G L
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.
Journal of the American College of Cardiology 1990;16(7):1529-34.
1990: Braunwald E
Optimizing thrombolytic therapy of acute myocardial infarction.
Circulation 1990;82(4):1510-3.
1990: Antman E M; Braunwald E
Acute MI management in the 1990s.
Hospital practice (Office ed.) 1990;25(7):65-75, 79-82.
1990: Braunwald E
On the natural history of severe aortic stenosis.
Journal of the American College of Cardiology 1990;15(5):1018-20.
1990: Pfeffer M A; Braunwald E
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
Circulation 1990;81(4):1161-72.
1990: Rutherford J D; Braunwald E
Thrombolytic therapy in acute myocardial infarction.
Chest 1990;97(4 Suppl):136S-145S.
1990: Baim D S; Braunwald E; Feit F; Knatterud G L; Passamani E R; Robertson T L; Rogers W J; Solomon R E; Williams D O
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives.
Journal of the American College of Cardiology 1990;15(5):1188-92.
1990: Chaitman B R; Thompson B W; Kern M J; Vandormael M G; Cohen M B; Ruocco N A; Solomon R E; Braunwald E
Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators.
American heart journal 1990;119(2 Pt 1):213-23.
1989: Braunwald E
Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator.
Journal of the American College of Cardiology 1989;14(6):1570-1.
1989: Braunwald E
Unstable angina. A classification.
Circulation 1989;80(2):410-4.
1989: Hands M E; Rutherford J D; Muller J E; Davies G; Stone P H; Parker C; Braunwald E
The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group.
Journal of the American College of Cardiology 1989;14(1):40-6; discussion 47-8.
1989: Pohjola-Sintonen S; Muller J E; Stone P H; Willich S N; Antman E M; Davis V G; Parker C B; Braunwald E
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.
American heart journal 1989;117(4):809-18.
1989: Wackers F J; Terrin M L; Kayden D S; Knatterud G; Forman S; Braunwald E; Zaret B L
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Journal of the American College of Cardiology 1989;13(5):998-1005.
1989: Rogers W J; Bourge R C; Papapietro S E; Wackers F J; Zaret B L; Forman S; Dodge H T; Robertson T L; Passamani E R; Braunwald E
Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
The American journal of cardiology 1989;63(9):503-12.
1989: Braunwald E
Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
Circulation 1989;79(2):441-4.
1989: Tofler G H; Muller J E; Stone P H; Willich S N; Davis V G; Poole W K; Robertson T; Braunwald E
Pericarditis in acute myocardial infarction: characterization and clinical significance.
American heart journal 1989;117(1):86-92.
1988: Braunwald E
Thrombolytic reperfusion of acute myocardial infarction: resolved and unresolved issues.
Journal of the American College of Cardiology 1988;12(6 Suppl A):85A-92A.
1988: Tofler G H; Muller J E; Stone P H; Willich S N; Davis V G; Poole W K; Braunwald E
Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients.
The American journal of cardiology 1988;62(13):860-7.
1988: Loscalzo J; Braunwald E
Tissue plasminogen activator.
The New England journal of medicine 1988;319(14):925-31.
1988: Dalen J E; Gore J M; Braunwald E; Borer J; Goldberg R J; Passamani E R; Forman S; Knatterud G
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
The American journal of cardiology 1988;62(4):179-85.
1988: Hands M E; Cook E F; Stone P H; Muller J E; Hartwell T; Sobel B E; Roberts R; Braunwald E; Rutherford J D
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block.
American heart journal 1988;116(1 Pt 1):23-31.
1988: Pfeffer M A; Lamas G A; Vaughan D E; Parisi A F; Braunwald E
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.
The New England journal of medicine 1988;319(2):80-6.
1988: Muller J E; Rude R E; Braunwald E; Hartwell T D; Roberts R; Sobel B E; Ritter C; Parker C B; Jaffe A S; Stone P H
Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size.
Annals of internal medicine 1988;108(1):1-6.
1988: Braunwald E
On future directions for cardiology. The Paul D. White lecture.
Circulation 1988;77(1):13-32.
1987: Laffel G L; Fineberg H V; Braunwald E
A cost-effectiveness model for coronary thrombolysis/reperfusion therapy.
Journal of the American College of Cardiology 1987;10(5 Suppl B):79B-90B.
1987: Braunwald E; Knatterud G L; Passamani E; Robertson T L; Solomon R
Update from the Thrombolysis in Myocardial Infarction Trial.
Journal of the American College of Cardiology 1987;10(4):970.
1987: Braunwald E; Knatterud G L; Passamani E R; Robertson T L
Announcement of protocol change in thrombolysis in myocardial infarction trial.
Journal of the American College of Cardiology 1987;9(2):467.
1986: Turi Z G; Stone P H; Muller J E; Parker C; Rude R E; Raabe D E; Jaffe A S; Hartwell T D; Robertson T L; Braunwald E
Implications for acute intervention related to time of hospital arrival in acute myocardial infarction.
The American journal of cardiology 1986;58(3):203-9.
1984: Hackel D B; Reimer K A; Ideker R E; Mikat E M; Hartwell T D; Parker C B; Braunwald E B; Buja M; Gold H K; Jaffe A S
Comparison of enzymatic and anatomic estimates of myocardial infarct size in man.
Circulation 1984;70(5):824-35.
1983: Smith J L; Ambos H D; Gold H K; Muller J E; Poole W K; Raabe D S; Rude R E; Passamani E; Braunwald E; Sobel B E; Roberts R
Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available.
The American journal of cardiology 1983;51(8):1294-300.

Sign-in to see more